Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Lucy Lu is Director at Veru. OQRO lists 2 transactions filed with the SEC under this name, the latest on May 6, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Veru
2 disclosures · Dec 2025 – May 2026
May 4, 2026104Kdisclosed May 6
DetailsOfficial recordDec 5, 20254,000disclosed Dec 9
DetailsOfficial recordLucy Lu bought shares on the open market in 2012, 2013, 2014, 2017, 2021 and 2023, and has not bought since 2023 across 2 companies.
Lucy Lu reported 10 open-market purchases and 0 sales since 2012; purchases in 6 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2023 | $10K1×1 trade | — |
| 2021 | $33K1×1 trade | — |
| 2017 | $5K1×1 trade | — |
| 2014 | $14K2×2 trades | — |
| 2013 | $94K4×4 trades | — |
| 2012 | $50K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Lucy Lu reported 8 open-market purchases and 0 sales here, 2012 to 2023.
Lucy Lu reported 2 open-market purchases and 0 sales here, 2017 to 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Lucy Lu bought shares on the open market in 2012, 2013, 2014, 2017, 2021 and 2023, and has not bought since 2023 across 2 companies.
In SEC filings since 2012: the latest open-market purchase is from 2023; no open-market sale is on record.
2 companies: Fortress Biotech (FBIO, 2012–2023), Veru (VERU, 2017–2021).
